Corvus Pharmaceuticals, Inc. — SCHEDULE 13G/A Filings
6 SCHEDULE 13G/A filings on record
This page lists all SCHEDULE 13G/A filings submitted to the SEC by Corvus Pharmaceuticals, Inc. (CRVS), sorted by most recent first. Each row links to the full filing on EdgarLookup. Corvus Pharmaceuticals, Inc. has filed 6 SCHEDULE 13G/A documents with the SEC since 2014. To view all SEC filings by Corvus Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
3
4
424B4
424B5
5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001004 | Mar 26, 2026 | — |
| SCHEDULE 13G/A | — | 0001104659-26-015263 | Feb 13, 2026 | — |
| SCHEDULE 13G/A | — | 0000919574-25-004851 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000919574-25-003240 | May 15, 2025 | — |
| SCHEDULE 13G/A | — | 0000919574-25-001469 | Feb 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000950170-25-019936 | Feb 13, 2025 | — |